Rapid point of care testing: the next frontier in pharmacogenomics.
作者信息
Leach Marc, Newman William G, McDermott John H
机构信息
Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester, M13 9WL, UK.
Division of Evolution, Infection & Genomics, School of Biological Sciences, The University of Manchester, Manchester, M13 9PL, UK.
出版信息
Pharmacogenomics. 2024;25(7):289-291. doi: 10.1080/14622416.2024.2366691. Epub 2024 Jul 23.
Abstract
摘要
相似文献
1
Rapid point of care testing: the next frontier in pharmacogenomics.即时快速检测：药物基因组学的下一个前沿领域。
Pharmacogenomics. 2024;25(7):289-291. doi: 10.1080/14622416.2024.2366691. Epub 2024 Jul 23.
2
The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.泛在药物基因组学联盟：让每一位欧洲公民都能实现有效的治疗优化。
Pharmacogenomics. 2017 Jul;18(11):1041-1045. doi: 10.2217/pgs-2017-0093. Epub 2017 Jul 7.
3
Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.利用临床数据存储库对药物基因组学指导的药物使用进行特征分析。
Clin Pharmacol Ther. 2017 Aug;102(2):340-348. doi: 10.1002/cpt.611. Epub 2017 Jun 5.
4
What do we need to transfer pharmacogenetics findings into the clinic?我们需要什么来将药物遗传学研究结果应用于临床？
Pharmacogenomics. 2018 May;19(7):589-592. doi: 10.2217/pgs-2018-0026. Epub 2018 Apr 27.
5
Variant discovery using next-generation sequencing and its future role in pharmacogenetics.利用下一代测序进行变异发现及其在药物遗传学中的未来作用。
Pharmacogenomics. 2020 May;21(7):471-486. doi: 10.2217/pgs-2019-0190. Epub 2020 Apr 27.
6
Clinical Trial Designs to Support Clinical Utility of Pharmacogenomic Testing.支持药物基因组学检测临床实用性的临床试验设计。
Pharmacotherapy. 2017 Sep;37(9):1000-1004. doi: 10.1002/phar.1971. Epub 2017 Jul 26.
7
Potential of whole-genome sequencing-based pharmacogenetic profiling.基于全基因组测序的药物遗传学分析的潜力。
Pharmacogenomics. 2021 Feb;22(3):177-190. doi: 10.2217/pgs-2020-0155. Epub 2021 Feb 1.
8
Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program.退伍军人事务部退伍军人药物基因组检测（PHASER）临床项目。
Pharmacogenomics. 2021 Feb;22(3):137-144. doi: 10.2217/pgs-2020-0173. Epub 2021 Jan 6.
9
Pharmacogenomic testing to support prescribing in primary care: a structured review of implementation models.药物基因组学检测在初级保健中的应用：实施模式的系统评价。
Pharmacogenomics. 2021 Aug;22(12):761-776. doi: 10.2217/pgs-2021-0032. Epub 2021 Sep 1.
10
Pharmacogenomics, precision medicine, and implications for anesthesia care.药物基因组学、精准医学及其对麻醉护理的影响。
Best Pract Res Clin Anaesthesiol. 2018 Jun;32(2):61-81. doi: 10.1016/j.bpa.2018.07.001. Epub 2018 Aug 6.
引用本文的文献
1
Development and Validation of a Rapid Point-of-Care CYP2C19 Genotyping Platform.即时检测CYP2C19基因分型快速平台的开发与验证
J Mol Diagn. 2025 Mar;27(3):209-215. doi: 10.1016/j.jmoldx.2024.12.001. Epub 2024 Dec 24.
本文引用的文献
1
Exploring NICU nurses' views of a novel genetic point-of-care test identifying neonates at risk of antibiotic-induced ototoxicity: A qualitative study.探讨 NICU 护士对一种新型基因即时检验用于识别新生儿抗生素致耳毒性风险的看法：一项定性研究。
J Adv Nurs. 2024 Aug;80(8):3359-3370. doi: 10.1111/jan.16045. Epub 2024 Jan 7.
2
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.一个 12 基因药物遗传学检测面板以预防药物不良反应：一项开放标签、多中心、对照、集群随机交叉实施研究。
Lancet. 2023 Feb 4;401(10374):347-356. doi: 10.1016/S0140-6736(22)01841-4.
3
Patient and public involvement in hearing research: opportunities, impact and reflections with case studies from the Manchester Centre for Audiology and Deafness.患者和公众参与听力研究：机遇、影响和案例研究反思——来自曼彻斯特听力学和耳聋中心的报告
Int J Audiol. 2024 Feb;63(2):146-154. doi: 10.1080/14992027.2022.2155881. Epub 2022 Dec 26.
4
Rapid Point-of-Care Genotyping to Avoid Aminoglycoside-Induced Ototoxicity in Neonatal Intensive Care.快速床边基因分型以避免新生儿重症监护中氨基糖苷类药物引起的耳毒性。
JAMA Pediatr. 2022 May 1;176(5):486-492. doi: 10.1001/jamapediatrics.2022.0187.
5
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update.临床药物遗传学实施联盟 CYP2C19 基因型和氯吡格雷治疗指南：2022 更新版。
Clin Pharmacol Ther. 2022 Nov;112(5):959-967. doi: 10.1002/cpt.2526. Epub 2022 Feb 8.
6
Pharmacogenetics to Avoid Loss of Hearing (PALOH) trial: a protocol for a prospective observational implementation trial.药物遗传学避免听力损失（PALOH）试验：一项前瞻性观察实施试验的方案。
BMJ Open. 2021 Jun 16;11(6):e044457. doi: 10.1136/bmjopen-2020-044457.
7
Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype.临床药物遗传学实施联盟基于 MT-RNR1 基因型指导使用氨基糖苷类药物。
Clin Pharmacol Ther. 2022 Feb;111(2):366-372. doi: 10.1002/cpt.2309. Epub 2021 Jun 20.
8
The rise of point-of-care genetics: how the SARS-CoV-2 pandemic will accelerate adoption of genetic testing in the acute setting.即时护理遗传学的兴起：SARS-CoV-2大流行将如何加速基因检测在急性病环境中的应用。
Eur J Hum Genet. 2021 Jun;29(6):891-893. doi: 10.1038/s41431-021-00816-x. Epub 2021 Feb 15.
9
Genetic testing in the acute setting: a round table discussion.急性病诊治中的基因检测：圆桌讨论。
J Med Ethics. 2020 Aug;46(8):531-532. doi: 10.1136/medethics-2019-106043. Epub 2020 Jul 10.
10
Aminoglycosides: An Overview.氨基糖苷类药物：概述
Cold Spring Harb Perspect Med. 2016 Jun 1;6(6):a027029. doi: 10.1101/cshperspect.a027029.
Zotero 插件